Coegin Pharma (NGM:COEGIN) FCF Yield %: -19.55 (As of Jun. 30, 2026)


NGM:COEGIN Coegin Pharma NGM:COEGIN
29 GF Score
Price kr3.50
! 2 Warning Signs
View Full Analysis

What is Coegin Pharma FCF Yield %?

Coegin Pharma NGM:COEGIN -3.31% 29 FCF Yield % is -19.55 as of Jun. 30, 2026. GuruFocus rates NGM:COEGIN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 1,415 Biotechnology companies, Coegin Pharma ranks worse than 66.5% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Coegin Pharma's Trailing 12-Month Free Cash Flow is kr-18.07 Mil, and Market Cap is kr93.95 Mil. Therefore, Coegin Pharma's FCF Yield % for today is -19.55%.

The historical rank and industry rank for Coegin Pharma's FCF Yield % or its related term are showing as below:

NGM:COEGIN' s FCF Yield % Range Over the Past 10 Years
Min: -943.64   Med: -661.89   Max: -17.15
Current: -19.55


During the past 9 years, the highest FCF Yield % of Coegin Pharma was -17.15%. The lowest was -943.64%. And the median was -661.89%.

NGM:COEGIN's FCF Yield % is ranked worse than
66.5% of 1415 companies
in the Biotechnology industry
Industry Median: -9.49 vs NGM:COEGIN: -19.55

Coegin Pharma's FCF Margin % for the quarter that ended in Mar. 2026 was -1,926.37%.


Coegin Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Coegin Pharma FCF Yield % Related Terms


Coegin Pharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Coegin Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coegin Pharma FCF Yield % Chart

Coegin Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -0.11 -0.46 -48.94 -24.68 -14.98

Coegin Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.52 -15.81 -9.93 -16.04 -20.23

NGM:COEGIN vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Coegin Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coegin Pharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's FCF Yield % falls into.


NGM:COEGIN
29GF Score
Coegin Pharma NGM:COEGIN
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coegin Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Coegin Pharma's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-16.546 / 110.45832
=-14.98%

Coegin Pharma's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-5.625 * 4 / 111.21899
=-20.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -19.55 mean?
Coegin Pharma (NGM:COEGIN) has a FCF Yield % of -19.55 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Coegin Pharma and its competitors. According to the industry distribution chart, Coegin Pharma ranks #941 out of 1415 companies in the Biotechnology industry, placing it in the top 66.5%.
Is Coegin Pharma's FCF Yield % too high?
Coegin Pharma's current FCF Yield % is -19.55. Based on the distribution chart, Coegin Pharma ranks #941 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Coegin Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Coegin Pharma's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Coegin Pharma ranks #941 out of 1415 companies for FCF Yield %. This places Coegin Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Coegin Pharma and its competitors. Coegin Pharma's current FCF Yield % is -19.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coegin Pharma stock overvalued right now?
Coegin Pharma (NGM:COEGIN) has a current FCF Yield % of -19.55. The current FCF Yield % is -19.55. Coegin Pharma's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Coegin Pharma (NGM:COEGIN), the current FCF Yield % is -19.55 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coegin Pharma Business Description

Other Exchanges 7Z6:Germany
Address c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
29GF Score

Get the complete analysis for NGM:COEGIN

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.50
Price